Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
252 | 41951 | 34.3 | 70% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
430 | 15698 | PHEOCHROMOCYTOMA//NEUROBLASTOMA//PRIMARY ALDOSTERONISM |
928 | 10457 | CONGENITAL ADRENAL HYPERPLASIA//21 HYDROXYLASE DEFICIENCY//CYP21A2 |
1479 | 7136 | GLUCOCORTICOID RECEPTOR//GLUCOCORTICOID RESISTANCE//TRANSREPRESSION |
1985 | 5079 | 11 BETA HYDROXYSTEROID DEHYDROGENASE//ALDOSTERONE//EPLERENONE |
2456 | 3581 | APECED//AIRE//ADRENAL INSUFFICIENCY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PHEOCHROMOCYTOMA | Author keyword | 1032 | 60% | 3% | 1140 |
2 | NEUROBLASTOMA | Author keyword | 739 | 35% | 4% | 1731 |
3 | ALDOSTERONE | Author keyword | 633 | 37% | 3% | 1354 |
4 | CONGENITAL ADRENAL HYPERPLASIA | Author keyword | 624 | 68% | 1% | 552 |
5 | 11 BETA HYDROXYSTEROID DEHYDROGENASE | Author keyword | 544 | 78% | 1% | 360 |
6 | PRIMARY ALDOSTERONISM | Author keyword | 532 | 76% | 1% | 374 |
7 | ADRENOCORTICAL CARCINOMA | Author keyword | 445 | 81% | 1% | 268 |
8 | 21 HYDROXYLASE DEFICIENCY | Author keyword | 399 | 86% | 0% | 203 |
9 | LAPAROSCOPIC ADRENALECTOMY | Author keyword | 369 | 85% | 0% | 192 |
10 | PARAGANGLIOMA | Author keyword | 271 | 42% | 1% | 498 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHEOCHROMOCYTOMA | 1032 | 60% | 3% | 1140 | Search PHEOCHROMOCYTOMA | Search PHEOCHROMOCYTOMA |
2 | NEUROBLASTOMA | 739 | 35% | 4% | 1731 | Search NEUROBLASTOMA | Search NEUROBLASTOMA |
3 | ALDOSTERONE | 633 | 37% | 3% | 1354 | Search ALDOSTERONE | Search ALDOSTERONE |
4 | CONGENITAL ADRENAL HYPERPLASIA | 624 | 68% | 1% | 552 | Search CONGENITAL+ADRENAL+HYPERPLASIA | Search CONGENITAL+ADRENAL+HYPERPLASIA |
5 | 11 BETA HYDROXYSTEROID DEHYDROGENASE | 544 | 78% | 1% | 360 | Search 11+BETA+HYDROXYSTEROID+DEHYDROGENASE | Search 11+BETA+HYDROXYSTEROID+DEHYDROGENASE |
6 | PRIMARY ALDOSTERONISM | 532 | 76% | 1% | 374 | Search PRIMARY+ALDOSTERONISM | Search PRIMARY+ALDOSTERONISM |
7 | ADRENOCORTICAL CARCINOMA | 445 | 81% | 1% | 268 | Search ADRENOCORTICAL+CARCINOMA | Search ADRENOCORTICAL+CARCINOMA |
8 | 21 HYDROXYLASE DEFICIENCY | 399 | 86% | 0% | 203 | Search 21+HYDROXYLASE+DEFICIENCY | Search 21+HYDROXYLASE+DEFICIENCY |
9 | LAPAROSCOPIC ADRENALECTOMY | 369 | 85% | 0% | 192 | Search LAPAROSCOPIC+ADRENALECTOMY | Search LAPAROSCOPIC+ADRENALECTOMY |
10 | PARAGANGLIOMA | 271 | 42% | 1% | 498 | Search PARAGANGLIOMA | Search PARAGANGLIOMA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PRIMARY HYPERALDOSTERONISM | 743 | 85% | 1% | 386 |
2 | LAPAROSCOPIC ADRENALECTOMY | 713 | 82% | 1% | 417 |
3 | PHEOCHROMOCYTOMA | 609 | 45% | 2% | 1032 |
4 | ADRENAL CORTICAL CARCINOMA | 555 | 84% | 1% | 300 |
5 | APPARENT MINERALOCORTICOID EXCESS | 541 | 75% | 1% | 388 |
6 | NEURO BLASTOMA | 484 | 46% | 2% | 776 |
7 | MALIGNANT PHEOCHROMOCYTOMA | 442 | 83% | 1% | 246 |
8 | ADRENOCORTICAL CARCINOMA | 418 | 70% | 1% | 345 |
9 | PRIMARY ALDOSTERONISM | 387 | 60% | 1% | 424 |
10 | CORTICOSTEROID 11 BETA DEHYDROGENASE | 376 | 92% | 0% | 146 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 225 | 15% | 3% | 1334 |
2 | ENDOCRINE RESEARCH | 141 | 30% | 1% | 393 |
3 | STEROIDS | 44 | 10% | 1% | 412 |
4 | BIOCHEMICAL ACTIONS OF HORMONES | 7 | 28% | 0% | 20 |
5 | RECEPTOR | 1 | 12% | 0% | 11 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline | 2008 | 537 | 109 | 94% |
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine | 2015 | 6 | 85 | 78% |
Neuroblastoma | 2007 | 635 | 185 | 61% |
Medical Progress: Recent Advances in Neuroblastoma. | 2010 | 322 | 58 | 67% |
Regulation of the adrenocortical stem cell niche: implications for disease | 2015 | 6 | 162 | 62% |
Neuroblastoma: Biological insights into a clinical enigma | 2003 | 987 | 163 | 71% |
GENE-REGULATION BY STEROID-HORMONES | 1989 | 3184 | 107 | 40% |
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders | 2011 | 237 | 664 | 60% |
Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see) | 2014 | 50 | 110 | 46% |
Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency | 2014 | 28 | 33 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GREENSLOPES HOSP | 74 | 81% | 0.1% | 44 |
2 | MOL HYPERTENS | 69 | 83% | 0.1% | 39 |
3 | HIGH BLOOD P SURE UNIT | 47 | 88% | 0.1% | 22 |
4 | SECT MED NEUROENDOCRINOL | 46 | 72% | 0.1% | 36 |
5 | REPROD ADULT ENDOCRINOL PROGRAM | 42 | 75% | 0.1% | 30 |
6 | ENDOCRINOL UNIT | 34 | 14% | 0.6% | 232 |
7 | PROGRAM REPROD ADULT ENDOCRINOL | 26 | 29% | 0.2% | 78 |
8 | PEDIAT REPROD ENDOCRINOL BRANCH | 23 | 29% | 0.2% | 68 |
9 | ADRENAL STEROID DISORDERS PROGRAM | 22 | 81% | 0.0% | 13 |
10 | MOL SYST TOXICOL | 21 | 48% | 0.1% | 32 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000002338 | PITUITARY ADENOMA//CRANIOPHARYNGIOMA//ACROMEGALY |
2 | 0.0000002172 | STEROIDS//OSW 1//SQUALAMINE |
3 | 0.0000002053 | MENOPAUSE//POLYCYSTIC OVARY SYNDROME//ESTROGEN |
4 | 0.0000001478 | OXYTOCIN//VASOPRESSIN//CORTICOTROPIN RELEASING FACTOR |
5 | 0.0000001471 | CYTOCHROME P450//GSTM1//GSTT1 |
6 | 0.0000001470 | REPRODUCTIVE BIOLOGY//FERTILITY AND STERILITY//HUMAN REPRODUCTION |
7 | 0.0000001402 | AQUAPORIN//HYPONATRAEMIA//ERYPTOSIS |
8 | 0.0000001320 | GROWTH HORMONE//GROWTH HORMONE & IGF RESEARCH//ENDOMETRIUM |
9 | 0.0000001280 | CARCINOMA RENAL CELL//ANGIOMYOLIPOMA//TUBEROUS SCLEROSIS |
10 | 0.0000001275 | TRANSCRIPTION FACTOR//ETS 1//C JUN |